Nutex Health (NUTX) Cost of Revenue (2010 - 2026)

Nutex Health (NUTX) has 17 years of Cost of Revenue data on file, last reported at $4.0 million in Q1 2026.

• Quarterly Cost of Revenue rose 5.47% year-over-year to $4.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $17.4 million (up 26.77% YoY) and the FY2025 annual result came in at $17.2 million, up 12.8% from the prior year.
• Cost of Revenue eased to $4.0 million in Q1 2026 per NUTX's latest filing, from $5.3 million in the prior quarter.
• The five-year high for Cost of Revenue was $5.3 million in Q1 2024, with the low at $2.4 million in Q4 2024.
• Average Cost of Revenue over 5 years is $3.7 million, with a median of $3.6 million recorded in 2024.
• The widest YoY moves for Cost of Revenue: up 168.32% in 2022, down 49.7% in 2022.
• Nutex Health's Cost of Revenue stood at $2.8 million in 2022, then gained by 21.89% to $3.4 million in 2023, then dropped by 29.73% to $2.4 million in 2024, then soared by 122.54% to $5.3 million in 2025, then dropped by 24.66% to $4.0 million in 2026.
• Business Quant data shows NUTX's Cost of Revenue at $4.0 million in Q1 2026, $5.3 million in Q4 2025, and $3.3 million in Q3 2025.